MedTrace Logo

The Antipyretic Efficacy of Oral and Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever.

NCT01891435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 434

Last updated 2013-07-03

No results posted yet for this study

Summary

A randomized clinical trial to check the antipyretic efficacy of oral and intravenous paracetamol and intramuscular diclofenac sodium in patients presenting with fever to emergency department.

Conditions

  • Fever
  • Reduction in Temperature

Interventions

DRUG

Oral paracetamol

after giving medicine temperature is checked every 30 minutes for 2 hours

DRUG

Intravenous paracetamol

after giving medicine temperature is checked every 30 minutes for 2 hours

DRUG

Intramuscular diclofenac

after giving medicine temperature is checked every 30 minutes for 2 hours

Sponsors & Collaborators

  • Hamad Medical Corporation

    lead INDUSTRY

Principal Investigators

  • osama H Mohammed · Hamad Medical Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-12-31
Completion
2013-04-30

Countries

  • Qatar

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01891435 on ClinicalTrials.gov